San Francisco, CA1 Active Studies

Myeloproliferative Neoplasms Clinical Trials in San Francisco, CA

Find 1 actively recruiting myeloproliferative neoplasms clinical trials in San Francisco, CA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
150
Enrolling

Recruiting Myeloproliferative Neoplasms Studies in San Francisco

About Myeloproliferative Neoplasms Clinical Trials in San Francisco

Myeloproliferative neoplasms (MPNs) are blood cancers in which the bone marrow overproduces red blood cells, platelets, or white blood cells. Types include polycythemia vera, essential thrombocythemia, and myelofibrosis. Treatment depends on the specific type and risk factors.

There are currently 1 myeloproliferative neoplasms clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 150 participants. Research is being sponsored by Disc Medicine, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myeloproliferative Neoplasms Clinical Trials in San Francisco — FAQ

Are there myeloproliferative neoplasms clinical trials in San Francisco?

Yes, there are 1 myeloproliferative neoplasms clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What myeloproliferative neoplasms treatments are being tested?

The 1 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for myeloproliferative neoplasms.

Data updated October 16, 2026 from ClinicalTrials.gov